Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perrone

Showing results (61-70 of 272) with videos related to

Pageof 28
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 1, 2024
Systematic review of adoption, reporting and impact of health-related quality of life in phase III non-inferiority trials of systemic oncology treatmentsSara Notarnicola, Lucrezia Zumstein, Jessica Paparo, et al.
JCO Oncology Practice|February 20, 2025
How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of ViewAngioletta Lasagna, Patrizia Cambieri, Fausto Baldanti, et al.
Surgery|February 12, 2011
Simultaneous restoration of voice function and digestive tract continuity in patients with synchronous primaries of hypopharynx and thoracic esophagus with pedicled ileocolon flapHung-Chi Chen, Bahar Bassiri Gharb, Antonio Rampazzo, et al.
ESMO Open|March 4, 2017
Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)Massimo Di Maio, Paolo Bruzzi, Francesco Perrone, et al.
Journal of Oncology Practice|May 25, 2019
Assessing Financial Toxicity in Patients With Cancer: Moving Away From a One-Size-Fits-All ApproachFrancesco Perrone, Massimo Di Maio, Fabio Efficace, et al.
JAMA Oncology|April 17, 2020
The Use of Not-Negative Conclusions to Describe Results of Formally Negative Trials Presented at Oncology MeetingsMassimo Di Maio, Marco Audisio, Claudia Cardone, et al.
Surgery|December 11, 2012
Evaluation and management of complications or functional problems at the recipient site after esophageal and voice reconstruction with free ileocolon flapFrancesco Perrone, Bahar Bassiri Gharb, Antonio Rampazzo, et al.
Cancers|November 11, 2022
The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-AnalysisCaterina Caminiti, Giuseppe Maglietta, Francesca Diodati, et al.
Life (Basel, Switzerland)|November 27, 2021
Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical TrialsRaimondo Di Liello, Maria Carmela Piccirillo, Laura Arenare, et al.
Cancers|November 12, 2013
Potentiality and boundaries of use of sorafenib in patients with hepatocellular carcinoma: awaiting the results of ongoing clinical trialsMassimo Di Maio, Gennaro Daniele, Maria Carmela Piccirillo, et al.
Pageof 28

Showing results (61-70 of 272) with videos related to

Sort By:
Pageof 28
European Journal of Cancer (Oxford, England : 1990)|April 1, 2024
Systematic review of adoption, reporting and impact of health-related quality of life in phase III non-inferiority trials of systemic oncology treatmentsSara Notarnicola, Lucrezia Zumstein, Jessica Paparo, et al.
JCO Oncology Practice|February 20, 2025
How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and Infectious Disease Specialist Point of ViewAngioletta Lasagna, Patrizia Cambieri, Fausto Baldanti, et al.
Surgery|February 12, 2011
Simultaneous restoration of voice function and digestive tract continuity in patients with synchronous primaries of hypopharynx and thoracic esophagus with pedicled ileocolon flapHung-Chi Chen, Bahar Bassiri Gharb, Antonio Rampazzo, et al.
ESMO Open|March 4, 2017
Methodological issues in the choice among different drugs approved for the same therapeutic indication: a position paper by the Italian Association of Medical Oncology (AIOM)Massimo Di Maio, Paolo Bruzzi, Francesco Perrone, et al.
Journal of Oncology Practice|May 25, 2019
Assessing Financial Toxicity in Patients With Cancer: Moving Away From a One-Size-Fits-All ApproachFrancesco Perrone, Massimo Di Maio, Fabio Efficace, et al.
JAMA Oncology|April 17, 2020
The Use of Not-Negative Conclusions to Describe Results of Formally Negative Trials Presented at Oncology MeetingsMassimo Di Maio, Marco Audisio, Claudia Cardone, et al.
Surgery|December 11, 2012
Evaluation and management of complications or functional problems at the recipient site after esophageal and voice reconstruction with free ileocolon flapFrancesco Perrone, Bahar Bassiri Gharb, Antonio Rampazzo, et al.
Cancers|November 11, 2022
The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-AnalysisCaterina Caminiti, Giuseppe Maglietta, Francesca Diodati, et al.
Life (Basel, Switzerland)|November 27, 2021
Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical TrialsRaimondo Di Liello, Maria Carmela Piccirillo, Laura Arenare, et al.
Cancers|November 12, 2013
Potentiality and boundaries of use of sorafenib in patients with hepatocellular carcinoma: awaiting the results of ongoing clinical trialsMassimo Di Maio, Gennaro Daniele, Maria Carmela Piccirillo, et al.
Pageof 28